These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 35337110)

  • 21. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.
    Griffin SJ; Leaver JK; Irving GJ
    Diabetologia; 2017 Sep; 60(9):1620-1629. PubMed ID: 28770324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose-lowering therapies in patients with type 2 diabetes and cardiovascular diseases.
    Prattichizzo F; La Sala L; Rydén L; Marx N; Ferrini M; Valensi P; Ceriello A
    Eur J Prev Cardiol; 2019 Dec; 26(2_suppl):73-80. PubMed ID: 31766918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. METFORMIN: NONGLYCEMIC EFFECTS AND POTENTIAL NOVEL INDICATIONS.
    Anabtawi A; Miles JM
    Endocr Pract; 2016 Aug; 22(8):999-1007. PubMed ID: 27579542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the role of repaglinide in the management of type 2 diabetes mellitus: a review.
    Johansen OE; Birkeland KI
    Am J Cardiovasc Drugs; 2007; 7(5):319-35. PubMed ID: 17953471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral antihyperglycemic treatment options for type 2 diabetes mellitus.
    Brietzke SA
    Med Clin North Am; 2015 Jan; 99(1):87-106. PubMed ID: 25456645
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus.
    Dunn CJ; Peters DH
    Drugs; 1995 May; 49(5):721-49. PubMed ID: 7601013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin for diabetes prevention: update of the evidence base.
    Hostalek U; Campbell I
    Curr Med Res Opin; 2021 Oct; 37(10):1705-1717. PubMed ID: 34281467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of Empagliflozin and Metformin Therapy: A Consideration of its Place in Type 2 Diabetes Therapy.
    Goldman JD
    Clin Med Insights Endocrinol Diabetes; 2018; 11():1179551418786258. PubMed ID: 30013414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worry vs. knowledge about treatment-associated hypoglycaemia and weight gain in type 2 diabetic patients on metformin and/or sulphonylurea.
    Lund A; Knop FK
    Curr Med Res Opin; 2012 May; 28(5):731-6. PubMed ID: 22462528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.
    Anholm C; Kumarathurai P; Klit MS; Kristiansen OP; Nielsen OW; Ladelund S; Madsbad S; Sajadieh A; Haugaard SB;
    BMJ Open; 2014 Jul; 4(7):e005942. PubMed ID: 25031198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis.
    Zhang K; Yang W; Dai H; Deng Z
    Diabetes Res Clin Pract; 2020 Feb; 160():108001. PubMed ID: 31904444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pleiotropic effects of metformin: time for prospective studies.
    Bromage DI; Yellon DM
    Cardiovasc Diabetol; 2015 Aug; 14():109. PubMed ID: 26271457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
    Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
    Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An investigation into the pleiotropic activity of metformin. A glimpse of haemostasis.
    Markowicz-Piasecka M; Sadkowska A; Huttunen KM; Podsiedlik M; Mikiciuk-Olasik E; Sikora J
    Eur J Pharmacol; 2020 Apr; 872():172984. PubMed ID: 32017937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of Cardiovascular Injury in Type 2 Diabetes and Potential Effects of Dipeptidyl Peptidase-4 Inhibition.
    Dokken B
    J Cardiovasc Nurs; 2016; 31(3):274-83. PubMed ID: 25829138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus.
    Raparelli V; Elharram M; Moura CS; Abrahamowicz M; Bernatsky S; Behlouli H; Pilote L
    J Am Heart Assoc; 2020 Jan; 9(1):e012940. PubMed ID: 31902326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    Sci Rep; 2021 Jan; 11(1):137. PubMed ID: 33420333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
    Peng Y; Chen SH; Liu XN; Sun QY
    J Cell Physiol; 2019 Mar; 234(3):2795-2806. PubMed ID: 30145806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.